[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Fu Xing Hospital, Capital Medical University\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":90},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,38,66],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":11,"sex":15,"minAge":4,"maxAge":4,"enrollmentInfo":16,"targetDuration":4,"studyType":19,"phases":4,"briefSummary":20,"conditions":21,"keywords":4,"overallStatus":25,"whyStopped":4,"lastUpdateSubmitDate":26,"lastUpdatePostDateStruct":27,"startDateStruct":30,"completionDateStruct":32,"leadSponsor":34,"locationsCount":37},"100582344","a-prospective-study-evaluating-the-impact-of-conservative-management-on-retained-products-of-conception-and-emv-100582344",false,"NCT06862089","A Prospective Study Evaluating the Impact of Conservative Management on Retained Products of Conception and EMV","Inclusion Criteria:\n\n* Recent history of miscarriage or delivery (within the past 8 weeks)\n* Strong willingness to undergo conservative management\n* Hemodynamically stable\n* Signed informed consent form\n\nExclusion Criteria:\n\n* Heavy vaginal bleeding (requiring immediate surgical intervention)\n* Active pelvic or systemic infection (e.g., fever \\>38°C, elevated CRP\u002FWBC)\n* Severe dysfunction of vital organs (heart, liver, or kidney)\n* Known drug allergies or contraindications to proposed medications (e.g., misoprostol intolerance)\n* Suspected ectopic pregnancy or gestational trophoblastic disease (confirmed by ultrasound or β-hCG levels)\n* Placenta accreta spectrum disorders diagnosed during current pregnancy\n* History of uterine artery embolization","FEMALE",{"count":17,"type":18},120,"ESTIMATED","OBSERVATIONAL","The goal of this observational study is to learn about the therapeutic effects of the conservative treatment approach on pepole with retained products of conception (RPOC) and Enhanced myometrial vascularity (EMV).\n\nThe main question it aims to answer is: Is it possible to achieve the natural resolution of RPOC by combining it with EMV through conservative treatment？ Participants will receive conservative treatment (such as mifepristone, GnRH-a, or expectant management) following the initial diagnosis of RPOC and EMV, and the therapeutic efficacy of the conservative approach will be assessed after the completion of two menstrual cycles.",[22,23,24],"Retained Products of Conception","Miscarriage","Conservative Management","RECRUITING","2025-06-12",{"date":28,"type":29},"2025-06-15","ACTUAL",{"date":31,"type":29},"2024-10-23",{"date":33,"type":18},"2026-12-30",{"name":35,"class":36},"Fu Xing Hospital, Capital Medical University","OTHER",1,{"id":39,"slug":40,"hasResults":11,"nctId":41,"briefTitle":42,"officialTitle":43,"acronym":4,"eligibilityCriteria":44,"healthyVolunteers":11,"sex":15,"minAge":45,"maxAge":46,"enrollmentInfo":47,"targetDuration":4,"studyType":49,"phases":50,"briefSummary":52,"conditions":53,"keywords":55,"overallStatus":58,"whyStopped":4,"lastUpdateSubmitDate":59,"lastUpdatePostDateStruct":60,"startDateStruct":62,"completionDateStruct":63,"leadSponsor":65,"locationsCount":4},"100586564","hysteroscopic-360-surgery-for-improvement-of-symptoms-in-cesarean-scar-defects-100586564","NCT06917014","Hysteroscopic \"360°\" Surgery for Improvement of Symptoms in Cesarean Scar Defects","A Randomized Controlled Study of Hysteroscopic \"360°\" Surgery for Improvement of Symptoms in Cesarean Scar Defects","Inclusion Criteria:\n\n* Patients with surgical adaptation: changes in menstruation after cesarean section (prolonged menstrual period)\n* No surgical contraindications;\n* Age 18-45 years old;\n* The thickness of residual muscle layer measured by ultrasound is greater than or equal to 2.5mm;\n* Patients with symptoms that have not improved significantly for more than 1 month after oral short-acting contraceptive cycle treatment or who strongly require surgery;\n* Understand and agree to the research plan.\n\nExclusion Criteria:\n\n* Patients with other diseases that may cause abnormal uterine bleeding (including endometrial polyps, endometrial hyperplasia, submucosal myoma, etc.) indicated by two-dimensional ultrasound\n* There are contraindications of surgery: such as severe internal and surgical complications, pregnancy, reproductive tract infection, malignant tumor;","18 Years","45 Years",{"count":48,"type":18},88,"INTERVENTIONAL",[51],"NA","Patients with symptomatic Cesarean Scar Defect (CSD) who are expected to undergo hysteroscopic surgery will be randomly divided into the traditional hysteroscopic \"channelization\" treatment group and the hysteroscopic \"360 °\" Surgery group of cesarean diverticulum, and the improvement of postoperative clinical symptoms of the two groups will be compared. To evaluate the effectiveness of the two surgical methods.\n\nThe purpose of this study was to evaluate the improvement of symptoms of women with symptomatic cesarean diverticulum through a high-quality randomized controlled study, in order to provide high-level evidence-based medical evidence for clinical treatment.",[54],"Cesarean Scar Defect",[56,57],"Hysteroscopic \"360°\" Surgery","Cesarean Scar Defects","NOT_YET_RECRUITING","2025-05-14",{"date":61,"type":29},"2025-05-16",{"date":61,"type":18},{"date":64,"type":18},"2029-11",{"name":35,"class":36},{"id":67,"slug":68,"hasResults":11,"nctId":69,"briefTitle":70,"officialTitle":71,"acronym":4,"eligibilityCriteria":72,"healthyVolunteers":11,"sex":15,"minAge":45,"maxAge":46,"enrollmentInfo":73,"targetDuration":4,"studyType":49,"phases":75,"briefSummary":76,"conditions":77,"keywords":78,"overallStatus":25,"whyStopped":4,"lastUpdateSubmitDate":82,"lastUpdatePostDateStruct":83,"startDateStruct":85,"completionDateStruct":87,"leadSponsor":89,"locationsCount":37},"100445794","the-efficacy-of-auto-cross-linked-hyaluronic-acid-gel-in-the-prevention-of-adhesion-reformation-after-hysteroscopic-resection-of-retained-products-of-conception-100445794","NCT05085067","The Efficacy of Auto-cross Linked Hyaluronic Acid Gel in the Prevention of Adhesion Reformation After Hysteroscopic Resection of Retained Products of Conception","The Efficacy of Auto-crosslinked Hyaluronic Acid Gel in the Prevention of Adhesion Reformation After Hysteroscopic Resection of Retained Products of Conception:a Randomized Controlled Trial","Inclusion Criteria:\n\n* Clinical diagnosis of retained products of conception\n* Written consent obtained\n\nExclusion Criteria:\n\n* Patients with severe complications of medicine and surgery\n* Acute or chronic genital tract inflammation\n* No understanding or approving the randomized controlled trial",{"count":74,"type":18},86,[51],"Retained product of conception (RPOC) is defined by abnormal trophoblastic persistence or retained placenta inside the uterus cavity after a pregnancy independently of the outcome. Untreated RPOC can compromise future fertility. RPOC are generally treated surgically, either by repeated evacuation or by hysteroscopy, which exposes the uterus to additional potential trauma.The combination of trauma to the gravid uterine cavity, hypoestrogenic state at the time of the operation or immediately afterward and local infection is considered to be the pathogenic mechanism of intrauterine adhesions (IUA) , manifested clinically by menstrual abnormalities, infertility and recurrent pregnancy loss.To investigate the efficacy of auto-cross linked hyaluronic acid gel in the prevention of adhesion reformation after hysteroscopic resection of retained products of conception.\n\nAfter the completion of hysteroscopic resection of retained products of conception, patients will be randomized to one of the two groups by computer-generated numbers: \\[1\\] infusing auto-cross linked hyaluronic acid gel into intrauterine cavity in the experimental group; \\[2\\] no auto-cross linked hyaluronic acid gel into intrauterine cavity in the control group. Second and third look outpatient hysteroscopy will be performed 4 and 8 weeks after the initial surgery. The patients will be followed up about menstrual pattern at 3 months after the surgery.The patients will be followed up about pregancy outcome at 12 months after the surgery.",[22],[22,79,80,81],"Hysteroscopy","Intrauterine adhesion","Auto-crossed-linked hyaluronic acid gel","2025-03-10",{"date":84,"type":29},"2025-03-12",{"date":86,"type":29},"2022-04-01",{"date":88,"type":18},"2025-05-30",{"name":35,"class":36},""]